Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-01

Clinical Trial Update: UCon Treatment of Overactive Bladder (OAB) in Males [NA]

View source ↗

Summary

A clinical trial update indicates that UCon for overactive bladder in males is currently recruiting, sponsored by InnoCon Medical.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • UCon

Snippet

Sponsor: InnoCon Medical | Conditions: Urinary Incontinence, Urge Incontinence | NA | Status: RECRUITING